What is the protocol for managing convulsions (seizures) in a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Neonatal Seizures Protocol

For active neonatal seizures, immediately administer lorazepam 0.1 mg/kg IV/IO, followed by phenobarbital 15-20 mg/kg IV loading dose if seizures persist, with levetiracetam 40 mg/kg IV as an alternative second-line agent. 1

Immediate Stabilization (First 2-5 Minutes)

Airway and Breathing:

  • Position infant in "sniffing" position to maintain patent airway 1, 2
  • Administer high-flow oxygen to prevent hypoxia 1, 2
  • Have equipment for airway protection and artificial ventilation immediately available 1, 3
  • Consider elective intubation if Glasgow coma score ≤8 1

Circulation and Access:

  • Establish IV or intraosseous access immediately 1
  • Monitor vital signs continuously, including oxygen saturation 1

Critical Initial Labs:

  • Check blood glucose urgently to rule out hypoglycemia 1, 2
  • Obtain calcium, magnesium, sodium, complete blood count, and blood culture if infection suspected 1

Temperature Management:

  • Place infant under radiant heat source to prevent hypothermia 1
  • Maintain normothermia—avoid both hypothermia and hyperthermia 1

Neurological Assessment

Rapid Evaluation:

  • Assess level of consciousness using AVPU scale (Alert, responds to Voice, responds to Pain, Unresponsive) 1
  • Check pupillary size and reaction to light—unilateral sluggish or absent responses indicate raised intracranial pressure 1
  • Observe for abnormal posturing or convulsive movements 1

Anticonvulsant Medication Protocol

First-Line Treatment:

  • Lorazepam 0.1 mg/kg IV/IO given slowly (2 mg/min maximum) 1, 3
  • If seizures persist after 5 minutes, repeat lorazepam dose (maximum 2 doses total) 1
  • Critical caveat: Monitor for respiratory depression, especially in neonates 1, 4

Second-Line Treatment (if seizures continue):

  • Levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) given as slow infusion over 5-10 minutes 1
  • Alternative: Phenobarbital 15-20 mg/kg IV loading dose (maximum 1,000 mg) 1, 5, 6
    • Therapeutic plasma levels (15-30 mcg/mL) achieved within minutes 5
    • 77% of neonatal seizures respond to phenobarbital at doses up to 40 mcg/mL serum concentration 6
    • Premature infants (<32 weeks) respond significantly better to phenobarbital 6

Third-Line Treatment:

  • If seizures persist despite phenobarbital loading to 40 mcg/mL serum concentration, add a second anticonvulsant rather than escalating phenobarbital further 6
  • Additional phenobarbital beyond 40 mcg/mL shows minimal additional benefit (only 10% response rate) 6

Maintenance Therapy After Seizure Control

Dosing Schedule:

  • Lorazepam: 0.05 mg/kg (maximum 1 mg) IV every 8 hours for 3 doses 1
  • Levetiracetam: 15 mg/kg (maximum 1,500 mg) IV every 12 hours 1
  • Phenobarbital: 3-5 mg/kg/day IV divided every 12 hours 1, 5, 7
    • Lower doses (3 mg/kg/day) for severe asphyxia 7
    • Higher doses (5 mg/kg/day) for neonates on ECMO support 7
    • Half-life is 59-182 hours in neonates, allowing once-daily dosing after loading 8

Critical Monitoring and Pitfalls

Respiratory Monitoring:

  • Major pitfall: Benzodiazepines and phenobarbital cause respiratory depression—have ventilatory support immediately available 1, 3
  • Rapid IV injection (<2 minutes) in neonates causes severe hypotension, especially when combined with fentanyl 4

Neurological Monitoring:

  • Monitor pupillary responses—most reliable sign of raised intracranial pressure 1
  • Document seizure cessation and any recurrence 1

Fluid Balance:

  • Maintain fluid balance records 1
  • Document vomiting or abdominal distention 1

Underlying Etiology Investigation

Common Causes to Consider:

  • Hypoxic-ischemic encephalopathy (most common) 1
  • Intracranial hemorrhage 1
  • Perinatal ischemic stroke 1
  • Infection (meningitis/sepsis)—obtain blood culture 1
  • Metabolic disorders (hypoglycemia, hypocalcemia, hypomagnesemia, hyponatremia) 1
  • Withdrawal-associated seizures (primarily myoclonic, respond to opiates) 2

When to Perform Lumbar Puncture:

  • Suspected meningitis based on clinical presentation 9
  • Children <12 months with prolonged seizures or incomplete recovery within 1 hour 9
  • Contraindication: Comatose infant or signs of raised intracranial pressure—perform brain imaging first 9

Team Coordination

Role Assignment:

  • Designate a team leader to coordinate care 1
  • Clearly assign roles to team members during resuscitation 1
  • Use closed-loop communication to prevent errors 1
  • Consider early pediatric neurology consultation 1

Transfer Considerations:

  • If specialized center transfer needed, discuss with receiving team early 1
  • Use pressure-redistributing mattresses and barrier creams under transport straps 1

Special Populations

Preterm Infants:

  • Avoid rapid IV injection (<2 minutes)—associated with severe hypotension and seizures 4
  • Reduced organ function increases vulnerability to prolonged respiratory effects 4
  • Better response to phenobarbital than term infants 6

Neonates with Renal/Hepatic Disease:

  • No acute dose adjustment needed for single doses 3
  • Exercise caution with frequent repeated doses over short periods 3

References

Guideline

Management of Neonatal Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Neonatal Seizures with Emphasis on Initial Assessment and Stabilization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Phenobarbital in newborn infants. Overview].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1984

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.